DUSU poll results 2025: Vote counting begins; ABVP, NSUI in close contest — Live updates

Delhi University Student Union elections saw a calmer polling day with a slight increase in voter turnout, reaching 39.4%. While voting was largely peaceful, the NSUI accused ABVP of vote manipulation, alleging marked EVMs. ABVP refuted the claims, citing NSUI’s frustration over their growing popularity. First-time voters expressed hopes for improved campus facilities and affordable…

Read More

‘Madharaasi’ OTT release: Sivakarthikeyan’s thriller heads to THIS platform; streaming Oct 3 – Reports

Sivakarthikeyan’s action thriller ‘Madharaasi,’ directed by A.R. Murugadoss, is set for its OTT release on Prime Video on October 3, 2025, following a mixed reception at the box office. The film, which explores a psychological twist with Fregoli delusion, features Vidyut Jammwal’s action and Anirudh Ravichander’s music, but faced criticism for its storyline and functional…

Read More

5 everyday signs you might be low on Vitamin B12

Vitamin B12 deficiency manifests through fatigue, nerve issues like tingling, mood changes, and memory problems. Skin discoloration, such as paleness or a yellowish tone, can also indicate a deficiency. A sore or inflamed tongue is another sign. Consulting a healthcare expert for diagnosis and treatment is crucial for maintaining balanced B12 levels and overall well-being.

Read More

‘License should be taken away’: Donald Trump wants to punish TV networks over ‘negative’ coverage; calls Jimmy Kimmel ‘untalented’

President Trump suggested potential government action against networks with negative coverage, even hinting at license revocation. This followed ABC’s suspension of Jimmy Kimmel after controversial remarks about Charlie Kirk, sparking protests and criticism. The controversy ignited after Kimmel’s comments on his show, leading to regulatory scrutiny and accusations of censorship, further intensifying the ongoing feud…

Read More

Colon cancer: THIS common over-the-counter medication slashes risk of colorectal cancer recurrence in half

A groundbreaking study reveals that a daily low dose of aspirin can significantly reduce the risk of colorectal cancer recurrence by approximately 55% in patients with specific PI3K pathway mutations. The ALASCCA trial demonstrated that aspirin, when taken for three years post-surgery, offers substantial benefits for those with these genetic alterations.

Read More